Being a xanathine oxidase (XO) inhibitor, Febuxostat is recommended to patients with gout and are also suffering from hyperuricemia. It is advisable to not prescribe this medicine to patient suffering from asymptomatic hyperuricemia. This medicine belongs to the category of organic compounds called as thiazolecarboxylic acids, which comprises of a thiazole ring having a carboxylic acid group. Moreover, it is metabolized by conjugation method via uridine diphosphate glucuronosyltransferase (UGT) enzymes.
Ethyl 2-(3-Formyl-4-Isobutoxy- phenyl) -4-Methylthiazole- 5-Carboxylate work as an intermediate required for the preparation of Febuxostat. Hence, it is prescribed in the treatment of hyperuricemia and gouty arthritis.